Company news
Clover Biopharmaceuticals Ltd. news in 2025
Clover Biopharmaceuticals Ltd.'s news releases, calls and decks from 2025, newest first.
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances
October 19, 2025
Clover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults
October 14, 2025
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
June 17, 2025
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
March 23, 2025